ArticleScientific reports2024

A novel anti-LAG-3/TIGIT bispecific antibody exhibits potent anti-tumor efficacy in mouse models as monotherapy or in combination with PD-1 antibody.

Tongcheng Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.